Clinical Trial Update: Stem Cell Transplantation to Treat Leukocyte Adhesion Deficiency [Phase 2]

View source ↗

Summary

Phase 2 trial of hematopoietic stem cell transplantation for Leukocyte adhesion deficiency syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukocyte Adhesion Deficiency

Drugs mentioned

• Hematopoietic stem cell transplantation

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Leukocyte-Adhesion Deficiency Syndrome | Phase 2 | Status: COMPLETED